MedPharm, Ltd. Expands Senior Leadership Team with New Senior Director of Sales & Marketing

Guildford, UK and Durham, NC, Jan. 26, 2024- MedPharm, Ltd., a global topical and transdermal CDMO, announced today that Daniel Morland has joined the company’s Senior Leadership Team as Senior Director of Sales & Marketing. This announcement follows the recent appointment of Lynn Allen as Chief Executive Officer.

Daniel Morland joined MedPharm in 2018 as a Senior Business Development Manager. He has more than 15 years of experience in the pharmaceutical industry with an emphasis on contract services. Dan has worked in sales and management roles at organizations such as Reading Scientific Services, Butterworth Laboratories, and Simbec-Orion. He holds an MBA from the University of Warwick Business School.

Speaking on his new role, Dan said, “I'm thrilled at the opportunity to return to MedPharm as part of Lynn Allen's leadership team. I look forward to supporting this world-class group as they continue to deliver the gold standard in topical and transdermal drug development solutions."

Dan will be based out of MedPharm’s Headquarters in Guildford, Surrey, and will lead the CDMO’s global commercial efforts.

“We are excited to welcome Dan back to MedPharm,” said Lynn Allen, CEO. “His deep knowledge of MedPharm’s services and breadth of experience will be key to MedPharm’s continued growth.”

About MedPharm

MedPharm is a global contract provider of topical and transdermal product design and formulation development services. For more than 20 years, MedPharm has specialized in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through its unique, cost-effective, and industry-leading performance testing models. Well-established as the global leader in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm also offers innovative solutions for ophthalmic and airway preparations. MedPharm has locations in both the United Kingdom and the United States and is recognized globally for its regulatory and technical expertise. For more information, visit medpharm.com or follow us on LinkedIn.